228.80USD-1.13%Mkt Cap: 32.77B $P/E: —1d ago
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence mon…
Indicators:|
Key Statistics
Company
Market Cap32.77B $
Enterprise Value32.29B $
Revenue (TTM)2.50B $
Gross Profit1.49B $
Net Income (TTM)-208.16M $
Revenue/Share18.07 USD
Last Price228.80 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees6.1K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1110.52
PEG—
EV/EBITDA-120.69
EV/Revenue12.91
P/S13.25
P/B18.62
EPS (TTM)-1.62
EPS (Forward)-0.21
52W Range
131.8178% of range256.36
52W High256.36 USD
52W Low131.81 USD
Profitability
Gross Margin64.75%
Oper. Margin-12.39%
EBITDA Margin-10.70%
Profit Margin-9.03%
ROE-12.16%
ROA-8.68%
Growth
Revenue Growth38.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF215.30M $
CapEx (TTM)139.19M $
FCF Margin5.47%
FCF Yield0.42%
Net Debt-847.85M $
Net Debt/EBITDA3.17
Balance Sheet
Debt/Equity0.13
Current Ratio2.96
Quick Ratio2.70
Book Value/Sh12.43 USD
Cash/Share7.596 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)260.05 USD
Upside (mean)+13.7%
Target Range193.00 USD – 300.00 USD
$193.00+13.7% to mean$300.00
# Analysts20
Ownership
Shares Out.143.22M
Float138.91M
Insiders3.02%
Institutions96.10%
Short Interest
Short Ratio2.1d
Short % Float2.60%
Short % Out.2.52%
Shares Short3.61M
Short (prev mo.)4.02M
Technical
SMA 50207.88 (+10.1%)
SMA 200206.57 (+10.8%)
Beta1.54
S&P 52W Chg24.49%
Avg Vol (30d)1.39M
Avg Vol (10d)1.26M
Technical Indicators
RSI (14)60.0
MACD5.5500
MACD Signal4.3270
MACD Hist.+1.2230
BB Upper232.89 USD
BB Middle216.58 USD
BB Lower200.27 USD
BB Width15.06%
ATR (14)10.99 USD
Vol Ratio (20d)1.20x